ASCENTAGE PHARMA
Ascentage Pharma develops novel small-molecule therapies for cancer, hepatitis B, and age-related diseases. They have developed a pipeline of seven drug candidates that disrupt complex and difficult-to-target protein-protein interactions and are next-generation tyrosine kinase inhibitors.
ASCENTAGE PHARMA
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2009-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.ascentagepharma.com
Total Employee:
101+
Status:
Active
Contact:
+86 512 855 57777
Email Addresses:
[email protected]
Total Funding:
312.49 M USD
Technology used in webpage:
Domain Not Resolving SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Alibaba AliDNS
Similar Organizations
CStone Pharmaceuticals
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
SyneuRx International Taiwan Corp.
SyneuRx is a bio-medical company that develops drugs for the treatment of central nervous system-related disorders.
T Cell Nouveau
T Cell Nouveau is a clinical-stage biopharmaceutical company that focuses on curing solid tumors with hybrid CAR-T cell therapy.
Tripod Preclinical Research Laboratories
Tripod provides preclinical research services for global pharma companies, R&D enterprises and institutes and medical device developers.
Current Employees Featured
Founder
Stock Details
Investors List
Takeda
Takeda investment in Post-IPO Equity - Ascentage Pharma
CTS Capital
CTS Capital investment in Series C - Ascentage Pharma
Teng Yue Partners
Teng Yue Partners investment in Series C - Ascentage Pharma
HDY International Investment
HDY International Investment investment in Series C - Ascentage Pharma
Oriza Seed Capital (Oriza Yuandian)
Oriza Seed Capital (Oriza Yuandian) investment in Series C - Ascentage Pharma
YuanMing Capital
YuanMing Capital investment in Series C - Ascentage Pharma
ArrowMark Partners
ArrowMark Partners investment in Series C - Ascentage Pharma
CCB International
CCB International investment in Series C - Ascentage Pharma
SDIC Fund Management
SDIC Fund Management investment in Series B - Ascentage Pharma
Oriza Holdings
Oriza Holdings investment in Series B - Ascentage Pharma
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-31 | Heluoxintu | Ascentage Pharma investment in Angel Round - Heluoxintu | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-29 | Ascentage Pharma Appoints Mr. Yiqing Chen as Chief Financial Officer |
Official Site Inspections
http://www.ascentagepharma.com
- Host name: catl.com
- IP address: 203.107.45.167
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Ascentage Pharma"
About Us - Ascentage Pharma
We are a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing both first- and best-in-class therapies to address global unmet medical needs …See details»
Ascentage Pharma - Crunchbase Company Profile & Funding
Organization. Ascentage Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email …See details»
Ascentage Pharma Group Company Profile | Management and
Www.ascentagepharma.com . Ascentage Pharma Group Profile and History. Ascentage Pharma is a globally-focused, clinical-stage biotechnology company engaged in developing novel …See details»
Leadership Team - Ascentage Pharma
Yifan Zhai, M.D., Ph.D., our chief medical officer, has over 30 years of experience in cancer research and new drug development at the National Cancer Institute, or NCI, and in the global …See details»
Ascentage Pharma - LinkedIn
Ascentage Pharma | 7,039 followers on LinkedIn. Ascentage Pharma is a global, clinical-stage biotechnology company engaged in developing novel therapies for cancers, CHB, and …See details»
首页 - 亚盛医药
亚盛医药于2020年7月，与国家血液系统疾病临床医学研究中心达成了战略合作，共建研究院，该研究院聚焦血液肿瘤领域，覆盖肿瘤基础研究、临床治疗研究、创新药物研发、创新人才培养 …See details»
Ascentage Pharma Group International
IR Contact: [email protected] Address: Level 1/2, Building 5, No. 338 Jialilue Road, Pudong New District, Shanghai Phone Number: 86–21–61951088. ... “CMO” a contract …See details»
Ascentage Pharma - LinkedIn
Ascentage Pharma | 5,855 followers on LinkedIn. Ascentage Pharma is a global, clinical-stage biotechnology company engaged in developing novel therapies for cancers, CHB, and …See details»
Ascentage Pharma Group International
Definitions 2 Corporate Information 10 Financial Highlights 12 Chairman’s Statement 13 Management Discussion and Analysis 14 Directors and Senior Management 30 Report of the …See details»
Ascentage Pharma Group
Integrated organization in China, United States, Europe and Australia Dedicated team Global development Strongpipeline. 3 Major Achievements in 2021 nThe first and the only approved …See details»
Ascentage Pharma Company Overview, Contact Details
[email protected]: 3%. See more formats. Frequently Asked Questions Where is Ascentage Pharma 's headquarters located? Ascentage Pharma 's main headquarters is …See details»
Ascentage Pharma Group - Overview, News & Similar companies
Apr 24, 2024 Who is Ascentage Pharma Group. Ascentage Pharma is a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, …See details»
Ascentage Pharma - Craft
Oct 25, 2024 Ascentage Pharma has 5 employees across 6 locations and ¥221.98 m in annual revenue in FY 2023. See insights on Ascentage Pharma including office locations, …See details»
Ascentage Pharma - Company Profile - Tracxn
Nov 5, 2024 Email ID: *****@ascentagepharma.com; Key Metrics. Total Funding. $238M in 3 rounds. Latest Funding Round. Series C, Jul 17, 2018, $150M. Investors. Oriza Ventures & 14 …See details»
Ascentage Pharma Group International
Definitions 2 Corporate Information 8 Financial Highlights 10 Business Highlights 11 Management Discussion and Analysis 12 Other Information 25 Independent Review Report 37 Interim …See details»
Partnerships - Ascentage Pharma
In July 2021, we and Innovent Biologics , announced a multifaceted strategic collaboration. This collaboration includes the joint clinical development and commercialization of …See details»
Ascentage Pharma Group
Major Achievements Over Last 12 Months 5 Clinical Proof of Concept (POC) of APG-2575 established inr/r CLL 1 NDA with “Priority Review” and“Breakthrough Therapy” for HQP1351 …See details»
Ascentage Pharma Group
2020 Key Achievements Clinical Proof of Concept (POC) of APG-2575 established in r/r CLL 9 ODD and 1 FTD (HQP1351 in TKI resistant CML) 2 global clinical collaborations with …See details»
ASCENTAGE PHARMA GROUP INTERNATIONAL
1. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. 2. Schrader A, …See details»